User profiles for "author:Arnav Agarwal"

Arnav Agarwal

Division of General Internal Medicine, Department of Medicine, McMaster University
Verified email at medportal.ca
Cited by 26030

Drug treatments for covid-19: living systematic review and network meta-analysis

RAC Siemieniuk, JJ Bartoszko, D Zeraatkar, E Kum… - bmj, 2020 - bmj.com
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …

[HTML][HTML] Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review

A Izcovich, MA Ragusa, F Tortosa, MA Lavena Marzio… - PloS one, 2020 - journals.plos.org
Background and purpose The objective of our systematic review is to identify prognostic
factors that may be used in decision-making related to the care of patients infected with …

Opioids for chronic noncancer pain: a systematic review and meta-analysis

JW Busse, L Wang, M Kamaleldin, S Craigie, JJ Riva… - Jama, 2018 - jamanetwork.com
Importance Harms and benefits of opioids for chronic noncancer pain remain unclear.
Objective To systematically review randomized clinical trials (RCTs) of opioids for chronic …

[HTML][HTML] Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the …

T Vos, C Allen, M Arora, RM Barber, ZA Bhutta… - The lancet, 2016 - thelancet.com
Background Non-fatal outcomes of disease and injury increasingly detract from the ability of
the world's population to live in full health, a trend largely attributable to an epidemiological …

[HTML][HTML] Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990 …

MH Forouzanfar, A Afshin, LT Alexander, HR Anderson… - The lancet, 2016 - thelancet.com
Summary Background The Global Burden of Diseases, Injuries, and Risk Factors Study
2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the …

[HTML][HTML] Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for …

H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta… - The lancet, 2016 - thelancet.com
Background Improving survival and extending the longevity of life for all populations
requires timely, robust evidence on local mortality levels and trends. The Global Burden of …

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

JL Brożek, J Bousquet, I Agache, A Agarwal… - Journal of Allergy and …, 2017 - Elsevier
Background Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of
life and school and work performance and is a frequent reason for office visits in general …

[HTML][HTML] Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

NJ Kassebaum, RM Barber, ZA Bhutta, L Dandona… - The lancet, 2016 - thelancet.com
Background In transitioning from the Millennium Development Goal to the Sustainable
Development Goal era, it is imperative to comprehensively assess progress toward reducing …

[HTML][HTML] Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a …

NJ Kassebaum, M Arora, RM Barber, ZA Bhutta… - The Lancet, 2016 - thelancet.com
Background Healthy life expectancy (HALE) and disability-adjusted life-years (DALYs)
provide summary measures of health across geographies and time that can inform …

A living WHO guideline on drugs for covid-19

A Agarwal, B Rochwerg, F Lamontagne… - 2022 - scholar.sun.ac.za
This living guideline by Arnav Agarwal and colleagues (BMJ 2020; 370: m3379, doi:
10.1136/bmj. m3379) was last updated on 22 April 2022, but the infographic contained two …